Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 17Completed 14Recruiting 8Not yet recruiting 6Terminated 3Withdrawn 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 1Esophageal Cancer Surgery 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Preoperative Exercise × Clear all
NCT03876561 2026-04-20

CONTICARE

Nantes University Hospital

Phase NA Terminated
120 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03798951 2024-01-22

PRESS

Università Vita-Salute San Raffaele

Phase NA Terminated
21 enrolled
Gastrointestinal

Esophageal Cancer Surgery

NCT04097795 2023-12-18

PreColo CU

Radboud University Medical Center

Terminated
72 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡